Topiramate: a new potential pharmacological treatment for obesity.
about
Combinations of drugs in the Treatment of Obesity.Topiramate improves neurovascular function, epidermal nerve fiber morphology, and metabolism in patients with type 2 diabetes mellitus.New drug policy in childhood obesity.Topiramate, pseudotumor cerebri, weight-loss and glaucoma: an ophthalmologic perspective.Phentermine and topiramate for the management of obesity: a review.Phentermine, sibutramine and affective disorders.Increased propensity for calcium phosphate kidney stones with topiramate use.Topiramate and type 2 diabetes: an old wine in a new bottle.Medications Development for the Treatment of Nicotine Dependence in Individuals with Schizophrenia.Efficacy of add-on topiramate therapy in psychiatric patients with weight gain.Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate.The insulin sensitizing effect of topiramate involves KATP channel activation in the central nervous systemPharmacotherapy for obesity: novel agents and paradigms.Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.Metabolic syndrome and bipolar disorder: what should psychiatrists know?A review of late-stage CNS drug candidates for the treatment of obesity.Topiramate stimulates glucose transport through AMP-activated protein kinase-mediated pathway in L6 skeletal muscle cells.[Recent progress and novel perspectives on obesity pharmacotherapy].
P2860
Q33664063-11EFC1DE-89C1-441D-8884-156928727E77Q33855470-D115BE1A-B604-4844-B03F-992A639F7AE4Q36356847-263ED538-771A-43F1-B760-87E2C59858E3Q36414182-1A7E6405-F241-42A0-8837-908C67A90D12Q36758207-B8EFECA3-818E-4B92-9C42-43421EF50A3EQ36832356-4A20CAAD-8A82-4C9A-B701-DE25A823B46DQ36945018-B012B6A2-F732-42E5-9CA2-08F83959B671Q37030881-1B3FBB00-C4F5-4CA3-BE96-F4E4C975139CQ37079797-5B58AC20-7E70-4C3C-97B9-41E0D14E6991Q37118263-3AC923F1-763E-4698-B789-3486849EA483Q37164665-DB207FF8-F5AE-4267-8883-89D743EDEB0EQ37237179-E45D8B43-C466-4AEB-A887-E36ADEBFDC7FQ37712227-30E7D84B-652F-46F3-BD60-BB0AA786B9D5Q37779809-2800C8E9-9B3E-4E29-B351-FE4A3250B39FQ37954425-E84B69F1-1170-40F9-A94B-72258D3CFB1BQ37992857-62CFBCFA-BC4C-424E-A0C1-B8D9C2B96A28Q40328873-A6389922-1AB8-4682-A50D-2010475E6310Q42881681-D75296A3-B44E-48B2-A276-E02AB6052C67
P2860
Topiramate: a new potential pharmacological treatment for obesity.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Topiramate: a new potential pharmacological treatment for obesity.
@ast
Topiramate: a new potential pharmacological treatment for obesity.
@en
type
label
Topiramate: a new potential pharmacological treatment for obesity.
@ast
Topiramate: a new potential pharmacological treatment for obesity.
@en
prefLabel
Topiramate: a new potential pharmacological treatment for obesity.
@ast
Topiramate: a new potential pharmacological treatment for obesity.
@en
P2860
P356
P1433
P1476
Topiramate: a new potential pharmacological treatment for obesity.
@en
P2093
Søren Toubro
P2860
P304
P356
10.1038/OBY.2004.284
P478
P50
P577
2004-12-01T00:00:00Z